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Grapefruit (Citrus paradisii) and shaddock (Citrus maxima) juices are used in folk medicine
for the management of hypertension and other cardiovascular diseases, but the mecha-
nism of action by which they exert their therapeutic action is unclear. The aim of this study
was to investigate the effect of grapefruit and shaddock juices on angiotensin-1-converting
enzyme (ACE) activity in vitro and the hypocholesterolemic properties of the juices in rats
fed a high-cholesterol diet. Grapefruit juice had higher total phenol and flavonoid contents
than shaddock juice, while both juices inhibited ACE activity in a dose-dependent manner.
Furthermore, administration of the juices to rats fed a high-cholesterol diet caused a sig-
nificant reduction in plasma total cholesterol, triglyceride, and low-density lipoprotein
echolesterol levels and an increase in high-density lipoproteinecholesterol levels. The
inhibition of ACE activity in vitro and in vivo hypocholesterolemic effect of the juices could
explain the use of the juices in the management of cardiovascular diseases.
Copyright © 2014, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.Open access under CC BY-NC-ND license. 1. Introduction
Cardiovascular diseases (CVDs) are regarded as the number
one cause of deathworldwide due to the fact thatmore people
die yearly fromCVDs than from any other cause, with >80% of
CVD deaths taking place in low- andmiddle-income countries
[1]. Of these worldwide deaths, an estimated 78% were due to
coronary heart disease and stroke [2]. CVDs are projected tond Nutraceutical Researc
Nigeria.
G. Oboh).
ministration, Taiwan. Publiremain the single leading cause of death worldwide, with
23.3 million sufferers expected by 2030 [3]. The development
of hypertension and other CVDs have been strongly linked
with hypercholesterolemia [4e6].
Citrus fruit species are one of the most popularly
consumed fruits in the world today and they are usually
consumed as fresh produce or juice [7]. The major bioactive
compounds in citrus juices are flavonoids, which occur in
different structural forms in a diversity of plants [8]. Theseh Unit, Department of Biochemistry, Federal University of Tech-
shed by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license. 
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and tangeretin and the flavanones, hesperetin, and nar-
ingenin [9]. Flavonoids have been associatedwith reduced risk
of certain chronic diseases and the prevention of certain
CVDs. [9]. Angiotensin-I-converting enzyme (ACE) is a dipep-
tidyl carboxypeptidase that catalyses the in vivo conversion of
angiotensin I (DRVYIHPFHL), found circulating in the plasma
into the potent vasopressor angiotensin II by removal of the C-
terminal HiseLeu [10]. The objectives of this project were to
investigate the hypocholesterolemic effect of two common
citrus fruit juices: grapefruit (Citrus paradisii) and shaddock
(Citrus aurantifolia).2. Methods
2.1. Sample collection and preparation
Two citrus fruits, grapefruit (C. paradisii) and shaddock
(C. aurantifolia) were purchased from Main Market, Akure,
Nigeria (Latitude 07 14IN, Longitude 05 11IE). The citrus fruits
were washed and the juice extracted by manual squeezing.
Reagents used include 1,10-phenanthroline, gallic acid, and
FolineCiocalteau's reagent, which were procured from Sig-
maeAldrich (St. Louis, MO, USA), methanol, sodium carbon-
ate, ethyl acetate, hydrochloric acid, TriseHCl, aluminum
chloride, and potassium acetate were sourced from BDH
Chemicals (Poole, Dorset, UK). All the kits used for bioassay
were sourced from Randox Laboratories Ltd. (Crumlin,
Antrim, UK). The water was glass distilled.
2.2. Determination of total phenol content
The total phenol content was determined according to the
method of Singleton et al [11]. Appropriate dilutions of the
juices were oxidized with 2.5 mL 10% FolineCiocalteau's re-
agent (v/v) and neutralized by 2.0 mL of 7.5% sodium car-
bonate. The reaction mixture was incubated for 40 minutes at
45C and the absorbance was measured at 765 nm in the
spectrophotometer. The total phenol content was subse-
quently calculated as gallic acid equivalent.
2.3. Determination of total flavonoid content
The total flavonoid content was determined using a slightly
modified method reported by Meda et al [12]. Briefly, 0.5 mL of
appropriately diluted samples were mixed with 0.5 mL
methanol, 50 mL 10% AlCl3, 50 mL 1M potassium acetate, and
1.4mLwater, and allowed to incubate at room temperature for
30 minutes. The absorbance of the reaction mixture was
subsequently measured at 415 nm and the total flavonoid
content calculated as quercetin equivalent.
2.4. ACE inhibition assay
The ACE inhibition was done using a slightlymodifiedmethod
of Cushman and Cheung [13]. Juice dilutions (0e50 mL) and
50 mL ACE (EC 3.4.15.1) solution were incubated at 37C for
15 minutes. The enzymatic reaction was initiated by adding
150 mL of 8.33mMof the substrate BzeGlyeHiseLeu in 125mMTriseHCl buffer (pH 8.3) to the mixture. After incubation for
30 minutes at 37C, the reaction was arrested by adding 250 mL
1M HCl. The GlyeHis bond was then cleaved and the BzeGly
produced by the reaction was extracted with 1.5 mL ethyl
acetate. Thereafter, the mixture was centrifuged at 1000g to
separate the ethyl acetate layer; then 1 mL of the ethyl acetate
layer was transferred to a clean test tube and evaporated. The
residue was redissolved in distilled water and its absorbance
was measured at 228 nm. Captopril in the therapeutic dose
range was used as a positive control.
2.5. Animals
Approval was obtained from the relevant departmental ethics
committee responsible for the use of laboratory animals. The
handling and use of the animals were in accordance with the
National Institutes for Health Guide for the Care and Use of
Laboratory Animals. Adult male Wistar rats weighing
80e130 g were purchased from the breeding colony of the
Department of Biochemistry, University of Ilorin, Ilorin,
Nigeria. The rats were maintained at 25C on a 12-hour
light/dark cycle with free access to food and water. They
were acclimatized under these conditions for 2 weeks prior to
the commencement of the experiments.
2.6. High cholesterol fed (hypercholesterolemia rat
model) bioassay
After 2 weeks of acclimatization, the rats were randomly
divided into nine groups of six animals each. Group I was fed
basal diet, Group II was fed basal diet containing 2% choles-
terol (positive control), Group III was fed basal diet containing
2% cholesterol with 0.3 mg/kg simvastatin, and Groups IVeIX
were administered citrus juices of varying concentrations
(0.5e2.0 mL) while being constantly fed basal diet plus 2%
cholesterol. The experiment lasted for 21 days, during which
the daily feed intake and weight gain were monitored
throughout the experiment that lasted for 21 days, after which
the animals were decapitated by cervical dislocation after an
overnight fast. The blood was rapidly collected by direct heart
puncture and the plasma was prepared. Total cholesterol,
high-density lipoprotein (HDL)echolesterol, triglyceride, and
low-density lipoprotein (LDL)echolesterol were determined
using commercially available kits (Randox Laboratories).
2.7. Preparation of plasma
At the end of the feeding trial, whole blood of the sacrificed
rats was collected into EDTA bottles and centrifuged at 800g
for 10 minutes to separate the plasma. The plasma was then
decanted into plain sample bottles and stored in a refrigerator
before analysis.
2.8. Determination of plasma triglyceride concentration
The triglyceride concentration was determined using a
colorimetric method as described by Tietz [14]. Briefly, 10 mL of
the sample was mixed with 1 mL PIPES reagent (40 mM
phosphate buffer, 5.5 mM 4-chlorophenol, and 17.5 mMMg2þ)
and enzyme reagent (4-aminophenazone, ATP, lipase, glycerol
Table 1 e Total phenol and flavonoid contents, EC50
values of ACE inhibition of grapefruit and shaddock
juices.
Grapefruit Shaddock
Total phenol (mg GAE/L) 134.7 ± 2.8a 100.3 ± 2.8b
Total flavonoid (mg QE/L) 35.0 ± 0.3a 29.7 ± 0.4b
ACE activity inhibition (mL/L) 2.51 ± 0.05b 2.24 ± 0.06a
Data are presented as mean ± standard deviation, n ¼ 3. Data with
the same superscript number on the same row are not significantly
(p < 0.05) different.
ACE ¼ angiotensin-I-converting enzyme; EC50 ¼ half maximal
effective concentration; GAE ¼ gallic acid equivalent;
QE ¼ quercetin equivalent.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 2 ( 2 0 1 4 ) 4 7 7e4 8 4 479kinase, glycerol-3-phosphate oxidase, and peroxidase).
Thereafter, the mixture was incubated for 5 minutes at 37C
and the absorbance at 546 nmwas taken against reagent blank
within 1 hour. The triglyceride concentration was subse-
quently calculated against the standard.
2.9. Determination of plasma total cholesterol
concentration
One milliliter of the reacting mixture containing 4-amino-
antipyrine, phenol, peroxidase, cholesterol esterase, choles-
terol oxidase and 80 mM PIPES buffer, pH 6.8, was mixed with
10 mL plasma and incubated for 5 minutes at 37C. The
absorbance at 546 nm was then taken against the reagent
blank within 1 hour. The concentration of cholesterol in the
sample was subsequently calculated against a standard.
2.10. Determination of plasma HDLecholesterol
concentration
The precipitation was carried out according to the method of
Lopes-Virella et al [15] as described in the kit manufacturer's
manual (Randox Laboratories). Briefly, 200 mL plasma was
mixed with 500 mL precipitant (0.55 mM phosphotungstic acid
and 25 mM magnesium chloride) and allowed to sit for 10
minutes at room temperature. The mixture was centrifuged
for 10 minutes at 800g. Thereafter, the clear supernatant was
separated off and subjected to the same procedure for the
determination of cholesterol, as described above.
2.11. Determination of plasma LDLecholesterol
concentration
The LDLecholesterol concentration of the plasma samples





2.12. Determination of artherogenic index
Artherogenic index was calculated as the ratio of
LDLecholesterol to HDLecholesterol.
2.13. Data analysis
The results of the replicates were expressed as
mean ± standard deviation. One-way analysis of variance and
the least significance difference were carried out. Significance
was accepted at p  0.05.3. Results
3.1. Total phenol and flavonoid contents
Table 1 shows that the total phenolic and flavonoid contents
of the juices reported as gallic acid equivalent revealed thatgrapefruit juice had significantly (p < 0.05) higher total
phenolic and flavonoid contents than shaddock juice.
3.2. Effect of citrus fruit juices on ACE activity
The interaction of the citrus fruit juices with ACE is presented
in Fig. 1 and it reveals that the juices inhibited ACE activity in a
dose-dependent manner. Shaddock juice had a significantly
higher (p < 0.05) inhibitory effect on ACE activity than grape-
fruit juice (Table 1). However, the juices had lower inhibition
of the enzyme activity than captopril.
3.3. Lipid profiles
In rats fed a high-cholesterol diet, triglyceride levels
decreased with increased quantities of citrus fruit juices
when compared to the controls (Fig. 2): grapefruit
(181.11 mg/dL vs. 143.15 mg/dL) and shaddock (167.91 mg/dL
vs. 136.21 mg/dL). The total cholesterol levels in the rats fed a
high-cholesterol diet with citrus fruit juices are shown in
Fig. 3. There was a decrease in total cholesterol with
increased quantities of citrus fruit juices when compared to
the controls: grapefruit (80.34 mg/dL vs. 54.51 mg/dL) and
shaddock (87.32 mg/dL vs. 60.32 mg/dL). The effect of citrus
fruit juices on plasma HDLecholesterol level is presented in
Fig. 4. There was a significant increase (p < 0.05) in plasma
HDLecholesterol in all the citrus fruit juice groups in relation
to the control group. The effect of the citrus fruit juices on
plasma LDLecholesterol level is presented in Fig. 5. There
was a significant decrease (p < 0.05) in plasma LDLecholes-
terol in all the citrus fruit juice groups in relation to the
control group. The effect of the citrus fruit juices on plasma
atherogenic index is presented in Fig. 6. There was a signifi-
cant decrease (p < 0.05) in atherogenic index in the rats
administered citrus fruit juice compared with the control
group. Table 2 shows that there was no significant difference
in the average food intake in all the groups, while there were
variations among the groups for percentage weight gain.4. Discussion
Evidence from population studies shows that a higher flavo-
noid intake may reduce the risk of CVD [17]. The citrus fruit
juices were both found to inhibit ACE activity in vitro, which
Fig. 1 e Interaction of citrus fruit juices with ACE. The citrus juices concentrations for the points are 0, 0.5 mL/L, 1.5 mL/L,
2.0 mL/L, and 2.5 mL/L. The captopril concentrations for the points are 0, 5.0 mg/L, 10.0 mg/L, 25.0 mg/L, and 50.0 mg/L.
Points with same annotation (*,**,***) along the plot are not significantly different. ACE ¼ angiotensin-I converting enzyme.
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ment of hypertension and heart failure. A lot of evidence ex-
ists in the literature linking hypertension to CVDs [18]. It is a
critical enzyme required in the rennineangiotensin system,
which regulates blood pressure, fluid and electrolyte homeo-
stasis, renal and vascular function, and myocardial remodel-
ing [19]. This ACE inhibition by the juices could be due to their
phenolic content as flavonoids; a class of polyphenols that has
been shown to inhibit ACE activity [20]. However, the
discrepancy observed in the flavonoid content and enzymeFig. 2 e Effect of citrus fruit juice administration on plasma trig
Basal¼ normal control rats fed basal diet; Control¼ rats fed a hi
a high-cholesterol diet receiving simvastatin orally; Grape (0.5
grapefruit juice; Grape (1.0 mL) ¼ rats fed high-cholesterol diet
fed high-cholesterol diet administered 2.0 mL grapefruit juice;
administered 0.5mL shaddock juice; Shaddock (1.0 mL)¼ rats fe
and Shaddock (2.0 mL) ¼ rats fed high-cholesterol diet adminis
(*,**,***) are not significantly different.inhibitory activity could be due to the variation in the flavo-
noids responsible for the activity of both juices.
Both juices caused a reduction in plasma triglyceride levels
in a dose-dependent manner, and this could have been due to
the ability of the citrus flavonoids to inhibit hepatic apolipo-
protein (apo)B secretion [21]. This causes a defect of trans-
location of apoB100 into the lumen of the endoplasmic
reticulum, increasing the amount of apoB100 degraded within
the hepatic cells [22]. This triglyceride-reducing effect is
important because an elevated plasma triglyceridelyceride level in rats fed a high-cholesterol diet.
gh-cholesterol diet (positive control); Simvastatin¼ rats fed
mL) ¼ rats fed high-cholesterol diet administered 0.5 mL
administered 1.0 mL grapefruit juice; Grape (2.0 mL) ¼ rats
Shaddock (0.5 mL) ¼ rats fed high-cholesterol diet
d high-cholesterol diet administered 1.0 mL shaddock juice;
tered 2.0 mL shaddock juice. Bars with same annotation
Fig. 3 e Effect of citrus fruit juice on plasma cholesterol level in rats fed a high-cholesterol diet. Basal ¼ normal control rats
fed basal diet; Control ¼ rats fed a high-cholesterol diet (positive control); Simvastatin ¼ rats fed a high-cholesterol diet
receiving simvastatin orally; Grape (0.5 mL) ¼ rats fed high-cholesterol diet administered 0.5 mL grapefruit juice; Grape
(1.0 mL)¼ rats fed high-cholesterol diet administered 1.0 mL grapefruit juice; Grape (2.0 mL)¼ rats fed high-cholesterol diet
administered 2.0 mL grapefruit juice; Shaddock (0.5 mL) ¼ rats fed high-cholesterol diet administered 0.5 mL shaddock
juice; Shaddock (1.0 mL)¼ high-cholesterol diet administered 1.0 mL shaddock juice; and Shaddock (2.0 mL)¼ rats fed high-
cholesterol diet administered 2.0 mL shaddock juice. Bars with same annotation (*,**,***) are not significantly different.
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dense LDL particles that are known to promote atheroscle-
rosis and other CVDs [23]. The citrus juices also caused a
reduction in cholesterol levels in the rats fed a high-
cholesterol diet, and other researchers have also observedFig. 4 e Effect of citrus fruit juice on plasma HDL level in rats fed a
diet; Control ¼ rats fed a high-cholesterol diet (positive control)
simvastatin orally; Grape (0.5 mL)¼ rats fed high-cholesterol die
fed high-cholesterol diet administered 1.0 mL grapefruit juice; G
2.0 mL grapefruit juice; Shaddock (0.5 mL) ¼ rats fed high-chole
(1.0 mL) ¼ rats fed high-cholesterol diet administered 1.0 mL sh
cholesterol diet administered 2.0 mL shaddock juice. Bars withthe cholesterol-reducing ability of citrus juices and naringin, a
major flavonone found in citrus juices [24]. The suggested
mechanism is that the citrus fruit juices possess the ability to
increase the bile flow and concentration of biliary bile
cholesterol and biliary bile acids, thereby enhancing excretionhigh-cholesterol diet. Basal¼ normal control rats fed basal
; Simvastatin ¼ rats fed a high-cholesterol diet receiving
t administered 0.5 mL grapefruit juice; Grape (1.0 mL)¼ rats
rape (2.0 mL) ¼ rats fed high-cholesterol diet administered
sterol diet administered 0.5 mL shaddock juice; Shaddock
addock juice; and Shaddock (2.0 mL) e ¼ rats fed high-
same annotation (*,**,***) are not significantly different.
Fig. 5 e Effect of citrus fruit juice on plasma LDL level in rats fed a high-cholesterol diet. Basal¼ normal control rats fed basal
diet; Control ¼ rats fed a high-cholesterol diet (positive control); Simvastatin ¼ rats fed a high-cholesterol diet receiving
simvastatin orally; Grape (0.5 mL)¼ rats fed high-cholesterol diet administered 0.5 mL grapefruit juice; Grape (1.0 mL)¼ rats
fed high-cholesterol diet administered 1.0 mL grapefruit juice; Grape (2.0 mL) ¼ rats fed high-cholesterol diet administered
2.0 mL grapefruit juice; Shaddock (0.5 mL) ¼ rats fed high-cholesterol diet administered 0.5 mL shaddock juice; Shaddock
(1.0 mL) ¼ rats fed high-cholesterol diet administered 1.0 mL shaddock juice; and Shaddock (2.0 mL) ¼ rats fed high-
cholesterol diet administered 2.0 mL shaddock juice. Bars with same annotation (*,**,***) are not significantly different.
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rats [25]. In patients diagnosed with coronary heart disease,
lower levels of the large HDL particles and higher levels of the
small and dense LDL particles have been observed in com-
parison with patients without coronary heart disease [26].Fig. 6 e Effect of citrus fruit juice on atherogenic index in rats f
Control ¼ rats fed a HCD (positive control); Simvastatin ¼ rats fe
fed HCD administered 0.5 mL grapefruit juice; Grape (1.0 mL)¼ r
mL) ¼ rats fed HCD administered 2.0 mL grapefruit juice; Shadd
juice; Shaddock (1.0 mL) ¼ rats fed HCD administered 1.0 mL s
administered 2.0 mL shaddock juice. Bars with same annotatioAlso, the major lipid abnormality present in patients with
known coronary heart disease is a low level of plasma HDL
cholesterol [27]. Both citrus fruit juices increased plasma HDL
levels and reduced LDL levels, which could explain the
observed differences in their hypocholesterolemic activity, ased HCD. Basal ¼ normal control rats fed basal diet;
d a HCD receiving simvastatin orally; Grape (0.5 mL) ¼ rats
ats fed HCD administered 1.0 mL grapefruit juice; Grape (2.0
ock (0.5 mL) ¼ rats fed HCD administered 0.5 mL shaddock
haddock juice; and Shaddock (2.0 mL) ¼ rats fed HCD
n (*,**,***) are not significantly different.
Table 2 e Average food intakes and weight gain of HPC rats administered citrus fruit juices.
Groupsa Diet treatments Food intake (g/rat/d) Weight gain (%)
I Normal control rats (basal) 9.8 ± 0.2a 7.6 ± 0.4a
II HPC control rats (basal) 9.9 ± 0.1a 21.9 ± 1.2b
III HPC control rats þ simvastatin 9.8 ± 0.2a 5.6 ± 0.4c
IV HPC control rats þ 0.5 mL grapefruit 9.8 ± 0.1a 14.2 ± 0.9d
V HPC control rats þ 1.0 mL grapefruit 9.8 ± 0.1a 9.2 ± 0.6e
VI HPC control rats þ 2.0 mL grapefruit 9.9 ± 0.1a 15.7 ± 0.8d
VII HPC control rats þ 0.5 mL shaddock 9.9 ± 0.1a 12.9 ± 1.1d
VIII HPC control rats þ 1.0 mL shaddock 9.8 ± 0.2a 8.4 ± 0.6a
IX HPC control rats þ 2.0 mL shaddock 9.7 ± 0.1a 6.5 ± 0.7c
HPC¼ hypercholesterolemic positive control, HCD ¼ high-cholesterol diet. Data with the same superscript number on the same column are not
significantly (p < 0.05) different.
a Group Ie normal control rats fed basal diet; Group IIe rats fed a HCD (positive control); Group IIIe rats fed a HCD receiving simvastatin orally;
Group IV e rats fed HCD administered 0.5 mL grapefruit juice; Group V e rats fed HCD administered 1.0 mL grapefruit juice; Group VI e rats fed
HCD administered 2.0mL grapefruit juice; Group VIIe rats fed HCD administered 0.5mL shaddock juice; Group VIIIe rats fed HCD administered
1.0 mL shaddock juice; and Group IX e rats fed HCD administered 2.0 mL shaddock juice.
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for this is that the flavonoids in the citrus juice act as cellular
signaling molecules regulating the signal transduction path-
ways of the sterol regulatory element binding proteins [28].
The sterol regulatory element binding proteins activated by
the flavonoids then activate the LDL receptor gene that in-
creases the cellular levels of the LDL receptor [29]. The net
effect of this is to reduce LDL levels in circulation and raise
HDL levels. The effect of the citrus juices on weight gain as
shown in Table 2 agrees with previous studies by Kurowska et
al., [17] where orange juice were shown to elevate plasma HDL
levels and reduce LDL levels and reduce weight gain.
In conclusion, the inhibition of a key enzyme linked with
hypertension (ACE), together with the hypocholesterolemic
effect of the juices observed on their administration to rats fed
a high-cholesterol diet could be part of the mechanism by
which the juices manage and/or prevent CVDs.r e f e r e n c e s
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